-
2
-
-
33847700815
-
Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer
-
Huang J, Liang ZD, Wu TT. Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer. Cancer Res 2007, 67:1589-93.
-
(2007)
Cancer Res
, vol.67
, pp. 1589-1593
-
-
Huang, J.1
Liang, Z.D.2
Wu, T.T.3
-
3
-
-
70149108742
-
Genetic variants of C1orf10 and risk of esophageal squamous cell carcinoma in a Chinese population
-
Zhang W, Chen X, Luo A, Lin D, Tan W, Liu Z. Genetic variants of C1orf10 and risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Sci 2009, 100:1695-700.
-
(2009)
Cancer Sci
, vol.100
, pp. 1695-1700
-
-
Zhang, W.1
Chen, X.2
Luo, A.3
Lin, D.4
Tan, W.5
Liu, Z.6
-
4
-
-
70349506738
-
Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma
-
Wang DF, Lou N, Zeng CG, Zhang X, Chen FJ. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Chin J Cancer 2009, 28:154-8.
-
(2009)
Chin J Cancer
, vol.28
, pp. 154-158
-
-
Wang, D.F.1
Lou, N.2
Zeng, C.G.3
Zhang, X.4
Chen, F.J.5
-
5
-
-
67650996833
-
Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China
-
Hu N, Wang C, Ng D. Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res 2009, 69:5908-17.
-
(2009)
Cancer Res
, vol.69
, pp. 5908-5917
-
-
Hu, N.1
Wang, C.2
Ng, D.3
-
6
-
-
70149117029
-
A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway
-
Li C, Chen H, Ding F. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem J 2009, 422:363-72.
-
(2009)
Biochem J
, vol.422
, pp. 363-372
-
-
Li, C.1
Chen, H.2
Ding, F.3
-
7
-
-
67449164585
-
Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma
-
Zhang C, Fu L, Fu J. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 2009, 15:4017-27.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4017-4027
-
-
Zhang, C.1
Fu, L.2
Fu, J.3
-
8
-
-
0037491744
-
N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
-
Deng Y, Yao L, Chau L. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 2003, 106:342-7.
-
(2003)
Int J Cancer
, vol.106
, pp. 342-347
-
-
Deng, Y.1
Yao, L.2
Chau, L.3
-
9
-
-
33845986380
-
The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter
-
Zhang J, Li F, Liu X. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Biol Chem 2006, 281:39159-68.
-
(2006)
J Biol Chem
, vol.281
, pp. 39159-39168
-
-
Zhang, J.1
Li, F.2
Liu, X.3
-
10
-
-
0035307347
-
Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart
-
Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001, 73:86-97.
-
(2001)
Genomics
, vol.73
, pp. 86-97
-
-
Zhou, R.H.1
Kokame, K.2
Tsukamoto, Y.3
Yutani, C.4
Kato, H.5
Miyata, T.6
-
11
-
-
0036184953
-
Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family
-
Qu X, Zhai Y, Wei H. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 2002, 229:35-44.
-
(2002)
Mol Cell Biochem
, vol.229
, pp. 35-44
-
-
Qu, X.1
Zhai, Y.2
Wei, H.3
-
12
-
-
2342538507
-
NDRG2: a novel Alzheimer's disease associated protein
-
Mitchelmore C, Buchmann-Moller S, Rask L, West MJ, Troncoso JC, Jensen NA. NDRG2: a novel Alzheimer's disease associated protein. Neurobiol Dis 2004, 16:48-58.
-
(2004)
Neurobiol Dis
, vol.16
, pp. 48-58
-
-
Mitchelmore, C.1
Buchmann-Moller, S.2
Rask, L.3
West, M.J.4
Troncoso, J.C.5
Jensen, N.A.6
-
13
-
-
1342287954
-
Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes
-
Nichols NR. Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes. Ann N Y Acad Sci 2003, 1007:349-56.
-
(2003)
Ann N Y Acad Sci
, vol.1007
, pp. 349-356
-
-
Nichols, N.R.1
-
14
-
-
47549118636
-
Immunohistochemical detection of Ndrg2 in the mouse nervous system
-
Shen L, Zhao ZY, Wang YZ. Immunohistochemical detection of Ndrg2 in the mouse nervous system. Neuroreport 2008, 19:927-31.
-
(2008)
Neuroreport
, vol.19
, pp. 927-931
-
-
Shen, L.1
Zhao, Z.Y.2
Wang, Y.Z.3
-
15
-
-
66549117990
-
Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation
-
Shi H, Jin H, Chu D. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull 2009, 32:968-75.
-
(2009)
Biol Pharm Bull
, vol.32
, pp. 968-975
-
-
Shi, H.1
Jin, H.2
Chu, D.3
-
16
-
-
64349090438
-
NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma
-
Kim YJ, Yoon SY, Kim JT. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis 2009, 30:598-605.
-
(2009)
Carcinogenesis
, vol.30
, pp. 598-605
-
-
Kim, Y.J.1
Yoon, S.Y.2
Kim, J.T.3
-
17
-
-
38049125779
-
Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death
-
Choi SC, Yoon SR, Park YP. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med 2007, 39:705-14.
-
(2007)
Exp Mol Med
, vol.39
, pp. 705-714
-
-
Choi, S.C.1
Yoon, S.R.2
Park, Y.P.3
-
18
-
-
49249103692
-
Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis
-
Lee DC, Kang YK, Kim WH. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res 2008, 68:4210-20.
-
(2008)
Cancer Res
, vol.68
, pp. 4210-4220
-
-
Lee, D.C.1
Kang, Y.K.2
Kim, W.H.3
-
19
-
-
70149120704
-
Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway
-
Shi H, Chen S, Jin H. Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci 2009, 100:1585-90.
-
(2009)
Cancer Sci
, vol.100
, pp. 1585-1590
-
-
Shi, H.1
Chen, S.2
Jin, H.3
-
20
-
-
0038147104
-
Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis
-
Maaser K, Daubler P, Barthel B. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis. Br J Cancer 2003, 88:1217-22.
-
(2003)
Br J Cancer
, vol.88
, pp. 1217-1222
-
-
Maaser, K.1
Daubler, P.2
Barthel, B.3
-
21
-
-
20244381388
-
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma
-
Hashimoto Y, Ito T, Inoue H. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11:2597-605.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2597-2605
-
-
Hashimoto, Y.1
Ito, T.2
Inoue, H.3
-
22
-
-
33644764887
-
An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo
-
Ito T, Hashimoto Y, Tanaka E. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 2006, 12:1308-16.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1308-1316
-
-
Ito, T.1
Hashimoto, Y.2
Tanaka, E.3
-
23
-
-
9244234933
-
NDRG2 expression and mutation in human liver and pancreatic cancers
-
Hu XL, Liu XP, Lin SX. NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol 2004, 10:3518-21.
-
(2004)
World J Gastroenterol
, vol.10
, pp. 3518-3521
-
-
Hu, X.L.1
Liu, X.P.2
Lin, S.X.3
-
24
-
-
34047270775
-
Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers
-
Wang Y, Liu DP, Chen PP, Koeffler HP, Tong XJ, Xie D. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res 2007, 67:2535-43.
-
(2007)
Cancer Res
, vol.67
, pp. 2535-2543
-
-
Wang, Y.1
Liu, D.P.2
Chen, P.P.3
Koeffler, H.P.4
Tong, X.J.5
Xie, D.6
-
25
-
-
52649132423
-
N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
-
Liu N, Wang L, Li X. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res 2008, 36:5335-49.
-
(2008)
Nucleic Acids Res
, vol.36
, pp. 5335-5349
-
-
Liu, N.1
Wang, L.2
Li, X.3
-
26
-
-
34250839385
-
P75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells
-
Jin H, Pan Y, Zhao L. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 2007, 9:471-8.
-
(2007)
Neoplasia
, vol.9
, pp. 471-478
-
-
Jin, H.1
Pan, Y.2
Zhao, L.3
-
27
-
-
23844451672
-
Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma
-
Lusis EA, Watson MA, Chicoine MR. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 2005, 15:7121-6.
-
(2005)
Cancer Res
, vol.15
, pp. 7121-7126
-
-
Lusis, E.A.1
Watson, M.A.2
Chicoine, M.R.3
-
28
-
-
74449083873
-
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma
-
Furuta H, Kondo Y, Nakahata S. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma. Biochem Biophys Res Commun 2010, 391:1785-91.
-
(2010)
Biochem Biophys Res Commun
, vol.391
, pp. 1785-1791
-
-
Furuta, H.1
Kondo, Y.2
Nakahata, S.3
-
29
-
-
34248185677
-
Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines
-
Liu N, Wang L, Liu X. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun 2007, 22:164-9.
-
(2007)
Biochem Biophys Res Commun
, vol.22
, pp. 164-169
-
-
Liu, N.1
Wang, L.2
Liu, X.3
-
30
-
-
55649103214
-
Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer
-
Zhao H, Zhang J, Lu J. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. BMC Cancer 2008, 22:303.
-
(2008)
BMC Cancer
, vol.22
, pp. 303
-
-
Zhao, H.1
Zhang, J.2
Lu, J.3
-
31
-
-
38349134575
-
NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells
-
Wang L, Liu N, Yao L. NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol Biochem 2008, 21:239-50.
-
(2008)
Cell Physiol Biochem
, vol.21
, pp. 239-250
-
-
Wang, L.1
Liu, N.2
Yao, L.3
-
32
-
-
34547899857
-
The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2)
-
Svensson E, Vidovic K, Olofsson T. The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2). DNA Cell Biol 2007, 26:589-97.
-
(2007)
DNA Cell Biol
, vol.26
, pp. 589-597
-
-
Svensson, E.1
Vidovic, K.2
Olofsson, T.3
|